| Financial Year |
March 31 2023 |
| Monetary Funds |
34,563,307.43 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
84,204,609.63 |
| Accounts Receivable |
9,634,334.49 |
| Advances to Suppliers |
12,444,017.92 |
| Other Receivables |
2,415,188.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
270,540,369.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
85,302.35 |
| Total Current Assets |
435,301,730.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,607,556.66 |
| Investment Properties |
-- |
| Fixed Assetes |
105,326,876.53 |
| Under-construction Projects |
14,892,762.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
942,365.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
122,769,560.58 |
| Total Assets |
558,071,291.47 |
| Short-Term Loans |
140,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,000,000.00 |
| Accounts Payable |
34,374,751.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,735,368.48 |
| Taxes Payable |
2,655,838.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,584,562.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
86,867,275.68 |
| Sub-Total of Current Liabilities |
417,229,059.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,570,453.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,508,428.90 |
| Total Liabilities |
476,737,488.40 |
| Paid-In Capital(Or Share Stock) |
307,495,600.00 |
| Capital Surplus |
734,444,022.23 |
| Surplus Reserve |
56,776,482.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,033,195,122.90 |
| Minority Stockholder's Interest |
-492,254.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
81,826,057.33 |
| Owner's Equity（Stockholder's Equity） |
81,333,803.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
558,071,291.47 |
